Web Results

en.wikipedia.org/wiki/Becaplermin

Becaplermin (brand name Regranex) is a cicatrizant, available as a topical gel. Regranex is a human platelet-derived growth factor indicated along with good ...

medlineplus.gov/druginfo/meds/a699049.html

Becaplermin Topical: learn about side effects, dosage, special precautions, and more on MedlinePlus.

www.rxlist.com/regranex-drug.htm

May 2, 2016 ... REGRANEX Gel contains becaplermin, a recombinant human platelet-derived growth factor for topical administration. Becaplermin is produced ...

www.drugbank.ca/drugs/DB00102

Becaplermin is produced by recombinant DNA technology by insertion of the gene for the B chain of platelet derived growth factor (PDGF) into the yeast, ...

www.regranex.com

Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients ...

www.medicinenet.com/becaplermin/article.htm

Becaplermin (Regranex) is a drug prescribed to people with diabetes to help heal diabetic ulcers of the lower limbs. Some serious side effects may occur.

www.ncbi.nlm.nih.gov/pubmed/15258509

Local toxicity studies in humans were negative (repeated becaplermin gel application under occlusion to intact or abraded skin, dermal sensitization tests).

reference.medscape.com/drug/regranex-gel-becaplermin-topical-343538

Medscape - Indication-specific dosing for Regranex Gel (becaplermin), frequency -based adverse effects, comprehensive interactions, contraindications, ...

www.aafp.org/afp/2008/0715/p255.html

Jul 15, 2008 ... Becaplermin (Regranex) topical gel is labeled for adjunctive treatment of stage III and IV diabetic neuropathic ulcers of the lower extremities.